Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

Clinical trial NCT07110246 · RECRUITING

Trial details

NCT number: NCT07110246
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

BRAF V600 Mutation Low-grade Glioma Low Grade Glioma of Brain Recurrent Low Grade Glioma

Start date: 2025-11-07
Primary completion: 2032-03-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.